Related Experiment Video
Updated: Aug 15, 2026
12:58
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
Expression of DHX32 in lymphoid tissues
Zaman Alli1, Michael Ho, Mohamed Abdelhaleem
1Division of Haematopathology, Department of Paediatric Laboratory Medicine, Room 3691, Atrium, Hospital for Sick Children, 555 University Avenue, Toronto, ON, Canada.
Experimental and Molecular Pathology
|September 27, 2005
Summary
DHX32, a novel RNA helicase, shows altered expression in leukemia and lymphoma. Its transcripts and protein are found in lymphoid tissues, suggesting a role in lymphocyte activation and differentiation.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- DHX32 is a newly identified RNA helicase.
- It is downregulated in acute lymphoblastic leukemia.
- The DHX32 gene exhibits complex alternative splicing and multiple promoters.
Purpose of the Study:
- To investigate the expression patterns of DHX32 transcripts and protein.
- To explore the role of DHX32 in normal lymphoid tissues and its dysregulation in lymphoid malignancies.
Main Methods:
- Reverse transcriptase (RT)-PCR with transcript-specific primers was used to analyze DHX32 transcripts.
- Immunohistochemistry was employed to study DHX32 protein expression.
- Expression analysis was performed on normal lymphoid tissues and lymphoma samples.
Main Results:
- All DHX32 transcripts were detected in thymus and spleen.
- DHX32 protein expression in normal lymphoid tissues varied and correlated with lymphocyte activation and differentiation.
- Dysregulated DHX32 expression was observed in certain lymphoma types compared to normal counterparts.
Conclusions:
- DHX32 is expressed in various forms in lymphoid tissues.
- Its expression is linked to lymphocyte activation and differentiation states.
- DHX32 may play a role in lymphoid malignancies, warranting further investigation.
